Semoxind — CAS 149845-06-7

Semoxind is a reversible monoamine oxidase inhibitor (RIMA) with antidepressant properties. It selectively and reversibly inhibits MAO-A, reducing the breakdown of serotonin, norepinephrine, and dopamine. Investigated for its role in major depressive disorder with a more favorable side-effect profile compared to irreversible MAO inhibitors. Mediocon Inc manufactures GMP-compliant Semoxind API at its Aurangabad facility.

• Major Depressive Disorder
• Reversible MAO-A inhibition
• Neuropsychiatric research
• Antidepressant formulations

• GMP Certified manufacturing facility in Aurangabad, Maharashtra, India
• Full pharmacopoeial compliance: IP / BP / EP / USP standards
• Complete documentation: Certificate of Analysis (CoA), MSDS, Certificate of Origin
• Stringent in-process quality control at every manufacturing stage
• HPLC purity testing and spectroscopic identification (IR, NMR)
• Cold-chain and controlled-environment storage facilities available
• Exported to 40+ countries with full regulatory support